Emerging role of ficolins in autoimmune diseases
[Display omitted] •Ficolins form complexes with mannose-binding lectin-associated serine proteases (MASPs) to trigger complement activation.•Ficolins regulate homeostasis by mediating immune responses of opsonization, phagocytosis and cytokine production.•Emerging evidence has suggested the major ro...
Gespeichert in:
Veröffentlicht in: | Pharmacological research 2021-01, Vol.163, p.105266-105266, Article 105266 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 105266 |
---|---|
container_issue | |
container_start_page | 105266 |
container_title | Pharmacological research |
container_volume | 163 |
creator | Wang, Peng Wu, Qian Shuai, Zong-Wen |
description | [Display omitted]
•Ficolins form complexes with mannose-binding lectin-associated serine proteases (MASPs) to trigger complement activation.•Ficolins regulate homeostasis by mediating immune responses of opsonization, phagocytosis and cytokine production.•Emerging evidence has suggested the major role of ficolins in the onset and development of autoimmune diseases (ADs).
Ficolins are pattern-recognition molecules (PRMs) that could form complexes with mannose-binding lectin-associated serine proteases (MASPs) to trigger complement activation via the lectin pathway, thereby mediating a series of immune responses including opsonization, phagocytosis and cytokine production. In the past few decades, accumulating evidence have suggested that ficolins play a major role in the onset and development of several autoimmune diseases (ADs), including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis (SSc), Type 1 diabetes (T1D), inflammatory bowel disease (IBD), etc. In this review, we synthesized previous literatures and recent advances to elucidate the immunological regulations of ficolins and discuss the potential diagnostic ability of ficolins in ADs, as well as giving an insight into the future therapeutic options for ficolins in ADs. |
doi_str_mv | 10.1016/j.phrs.2020.105266 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2456430699</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1043661820315747</els_id><sourcerecordid>2456430699</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-4b9b9db4d68bf3691951b63c31c9a658b060ea5c9abb81afd84c19d1b0eb2f143</originalsourceid><addsrcrecordid>eNp9kMlOwzAQhi0EoqXwAhxQjlxSPHHsxhIXVJVFqsQFzpaXSXGVpdgJEm9PohSOnGbRN780HyHXQJdAQdztl4ePEJcZzcYFz4Q4IXOgUqQAhTgd-5ylQkAxIxcx7imlMgd6TmaMQbbifDUndFNj2Plml4S2wqQtk9LbtvJNTHyT6L5rfV33DSbOR9QR4yU5K3UV8epYF-T9cfO2fk63r08v64dtahkXXZobaaQzuROFKZmQIDkYwSwDK7XghaGCoubDYEwBunRFbkE6MBRNVkLOFuR2yj2E9rPH2KnaR4tVpRts-6iynIucUSHlgGYTakMbY8BSHYKvdfhWQNVoSu3VaEqNptRkaji6Oeb3pkb3d_KrZgDuJwCHL788BhWtx8ai8wFtp1zr_8v_AXMVeT4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2456430699</pqid></control><display><type>article</type><title>Emerging role of ficolins in autoimmune diseases</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Wang, Peng ; Wu, Qian ; Shuai, Zong-Wen</creator><creatorcontrib>Wang, Peng ; Wu, Qian ; Shuai, Zong-Wen</creatorcontrib><description>[Display omitted]
•Ficolins form complexes with mannose-binding lectin-associated serine proteases (MASPs) to trigger complement activation.•Ficolins regulate homeostasis by mediating immune responses of opsonization, phagocytosis and cytokine production.•Emerging evidence has suggested the major role of ficolins in the onset and development of autoimmune diseases (ADs).
Ficolins are pattern-recognition molecules (PRMs) that could form complexes with mannose-binding lectin-associated serine proteases (MASPs) to trigger complement activation via the lectin pathway, thereby mediating a series of immune responses including opsonization, phagocytosis and cytokine production. In the past few decades, accumulating evidence have suggested that ficolins play a major role in the onset and development of several autoimmune diseases (ADs), including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis (SSc), Type 1 diabetes (T1D), inflammatory bowel disease (IBD), etc. In this review, we synthesized previous literatures and recent advances to elucidate the immunological regulations of ficolins and discuss the potential diagnostic ability of ficolins in ADs, as well as giving an insight into the future therapeutic options for ficolins in ADs.</description><identifier>ISSN: 1043-6618</identifier><identifier>EISSN: 1096-1186</identifier><identifier>DOI: 10.1016/j.phrs.2020.105266</identifier><identifier>PMID: 33127557</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Animals ; Autoimmune diseases ; Autoimmune Diseases - drug therapy ; Autoimmune Diseases - immunology ; Autoimmunity ; Ficolins ; Humans ; Lectins - chemistry ; Lectins - genetics ; Lectins - immunology</subject><ispartof>Pharmacological research, 2021-01, Vol.163, p.105266-105266, Article 105266</ispartof><rights>2020 Elsevier Ltd</rights><rights>Copyright © 2020 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-4b9b9db4d68bf3691951b63c31c9a658b060ea5c9abb81afd84c19d1b0eb2f143</citedby><cites>FETCH-LOGICAL-c356t-4b9b9db4d68bf3691951b63c31c9a658b060ea5c9abb81afd84c19d1b0eb2f143</cites><orcidid>0000-0002-5708-6509</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.phrs.2020.105266$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33127557$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Peng</creatorcontrib><creatorcontrib>Wu, Qian</creatorcontrib><creatorcontrib>Shuai, Zong-Wen</creatorcontrib><title>Emerging role of ficolins in autoimmune diseases</title><title>Pharmacological research</title><addtitle>Pharmacol Res</addtitle><description>[Display omitted]
•Ficolins form complexes with mannose-binding lectin-associated serine proteases (MASPs) to trigger complement activation.•Ficolins regulate homeostasis by mediating immune responses of opsonization, phagocytosis and cytokine production.•Emerging evidence has suggested the major role of ficolins in the onset and development of autoimmune diseases (ADs).
Ficolins are pattern-recognition molecules (PRMs) that could form complexes with mannose-binding lectin-associated serine proteases (MASPs) to trigger complement activation via the lectin pathway, thereby mediating a series of immune responses including opsonization, phagocytosis and cytokine production. In the past few decades, accumulating evidence have suggested that ficolins play a major role in the onset and development of several autoimmune diseases (ADs), including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis (SSc), Type 1 diabetes (T1D), inflammatory bowel disease (IBD), etc. In this review, we synthesized previous literatures and recent advances to elucidate the immunological regulations of ficolins and discuss the potential diagnostic ability of ficolins in ADs, as well as giving an insight into the future therapeutic options for ficolins in ADs.</description><subject>Animals</subject><subject>Autoimmune diseases</subject><subject>Autoimmune Diseases - drug therapy</subject><subject>Autoimmune Diseases - immunology</subject><subject>Autoimmunity</subject><subject>Ficolins</subject><subject>Humans</subject><subject>Lectins - chemistry</subject><subject>Lectins - genetics</subject><subject>Lectins - immunology</subject><issn>1043-6618</issn><issn>1096-1186</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMlOwzAQhi0EoqXwAhxQjlxSPHHsxhIXVJVFqsQFzpaXSXGVpdgJEm9PohSOnGbRN780HyHXQJdAQdztl4ePEJcZzcYFz4Q4IXOgUqQAhTgd-5ylQkAxIxcx7imlMgd6TmaMQbbifDUndFNj2Plml4S2wqQtk9LbtvJNTHyT6L5rfV33DSbOR9QR4yU5K3UV8epYF-T9cfO2fk63r08v64dtahkXXZobaaQzuROFKZmQIDkYwSwDK7XghaGCoubDYEwBunRFbkE6MBRNVkLOFuR2yj2E9rPH2KnaR4tVpRts-6iynIucUSHlgGYTakMbY8BSHYKvdfhWQNVoSu3VaEqNptRkaji6Oeb3pkb3d_KrZgDuJwCHL788BhWtx8ai8wFtp1zr_8v_AXMVeT4</recordid><startdate>202101</startdate><enddate>202101</enddate><creator>Wang, Peng</creator><creator>Wu, Qian</creator><creator>Shuai, Zong-Wen</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5708-6509</orcidid></search><sort><creationdate>202101</creationdate><title>Emerging role of ficolins in autoimmune diseases</title><author>Wang, Peng ; Wu, Qian ; Shuai, Zong-Wen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-4b9b9db4d68bf3691951b63c31c9a658b060ea5c9abb81afd84c19d1b0eb2f143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Autoimmune diseases</topic><topic>Autoimmune Diseases - drug therapy</topic><topic>Autoimmune Diseases - immunology</topic><topic>Autoimmunity</topic><topic>Ficolins</topic><topic>Humans</topic><topic>Lectins - chemistry</topic><topic>Lectins - genetics</topic><topic>Lectins - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Peng</creatorcontrib><creatorcontrib>Wu, Qian</creatorcontrib><creatorcontrib>Shuai, Zong-Wen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacological research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Peng</au><au>Wu, Qian</au><au>Shuai, Zong-Wen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Emerging role of ficolins in autoimmune diseases</atitle><jtitle>Pharmacological research</jtitle><addtitle>Pharmacol Res</addtitle><date>2021-01</date><risdate>2021</risdate><volume>163</volume><spage>105266</spage><epage>105266</epage><pages>105266-105266</pages><artnum>105266</artnum><issn>1043-6618</issn><eissn>1096-1186</eissn><abstract>[Display omitted]
•Ficolins form complexes with mannose-binding lectin-associated serine proteases (MASPs) to trigger complement activation.•Ficolins regulate homeostasis by mediating immune responses of opsonization, phagocytosis and cytokine production.•Emerging evidence has suggested the major role of ficolins in the onset and development of autoimmune diseases (ADs).
Ficolins are pattern-recognition molecules (PRMs) that could form complexes with mannose-binding lectin-associated serine proteases (MASPs) to trigger complement activation via the lectin pathway, thereby mediating a series of immune responses including opsonization, phagocytosis and cytokine production. In the past few decades, accumulating evidence have suggested that ficolins play a major role in the onset and development of several autoimmune diseases (ADs), including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis (SSc), Type 1 diabetes (T1D), inflammatory bowel disease (IBD), etc. In this review, we synthesized previous literatures and recent advances to elucidate the immunological regulations of ficolins and discuss the potential diagnostic ability of ficolins in ADs, as well as giving an insight into the future therapeutic options for ficolins in ADs.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>33127557</pmid><doi>10.1016/j.phrs.2020.105266</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-5708-6509</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1043-6618 |
ispartof | Pharmacological research, 2021-01, Vol.163, p.105266-105266, Article 105266 |
issn | 1043-6618 1096-1186 |
language | eng |
recordid | cdi_proquest_miscellaneous_2456430699 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Animals Autoimmune diseases Autoimmune Diseases - drug therapy Autoimmune Diseases - immunology Autoimmunity Ficolins Humans Lectins - chemistry Lectins - genetics Lectins - immunology |
title | Emerging role of ficolins in autoimmune diseases |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T05%3A08%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Emerging%20role%20of%20ficolins%20in%20autoimmune%20diseases&rft.jtitle=Pharmacological%20research&rft.au=Wang,%20Peng&rft.date=2021-01&rft.volume=163&rft.spage=105266&rft.epage=105266&rft.pages=105266-105266&rft.artnum=105266&rft.issn=1043-6618&rft.eissn=1096-1186&rft_id=info:doi/10.1016/j.phrs.2020.105266&rft_dat=%3Cproquest_cross%3E2456430699%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2456430699&rft_id=info:pmid/33127557&rft_els_id=S1043661820315747&rfr_iscdi=true |